(Q37920769)

25 August 2017

1 reference

title

Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review (English)

1 reference

25 August 2017

1 reference

3

1 reference

25 August 2017

5

Kazuhiko Koike

1 reference

25 August 2017

author name string

Luis Calzadilla Bertot

series ordinal

1

1 reference

25 August 2017

Masaya Sato

series ordinal

2

1 reference

25 August 2017

Haruhiko Yoshida

series ordinal

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

20 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

12

1 reference

25 August 2017

page(s)

2584-2596

1 reference

https://scigraph.springernature.com/pub.10.1007/s00330-011-2222-3

25 August 2017

exact match

0 references

cites work

Radiofrequency ablation of liver tumors: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Adverse events during radiofrequency treatment of 582 hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Quality improvement guidelines for radiofrequency ablation of liver tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Image-guided tumor ablation: standardization of terminology and reporting criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Challenges in systematic reviews that assess treatment harms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Systematic reviews of adverse effects: framework for a structured approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radio-frequency ablation of colorectal liver metastases in 167 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

The safety of radiofrequency thermal ablation in the treatment of liver malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Seeding risk following percutaneous approach to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Radiofrequency ablation for subcapsular hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Severe Complications of Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: An Analysis of 3,891 Ablations in 2,614 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2222-3

Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

12 December 2020

Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation

1 reference

12 December 2020

Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study

1 reference

12 December 2020

Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy

1 reference

12 December 2020

Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients

1 reference

12 December 2020

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

1 reference

12 December 2020

Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results

1 reference

12 December 2020

Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver

1 reference

12 December 2020

Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma

1 reference

12 December 2020

Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?

1 reference

12 December 2020

Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study

1 reference

12 December 2020

Radiofrequency ablation of liver tumors (I): biological background

1 reference

12 December 2020

Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series

1 reference

12 December 2020

Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC.

1 reference

12 December 2020

Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update

1 reference

12 December 2020

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors

1 reference

12 December 2020

Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma

1 reference

12 December 2020

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

12 December 2020

Quality Improvement Guidelines for the Reporting and Archiving of Interventional Radiology Procedures

1 reference

12 December 2020

10.1007/S00330-011-2222-3

Identifiers

DOI

1 reference

25 August 2017

1 reference